COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 321: Articles 3201-3210  | Next

Pretrainable Geometric Graph Neural Network for Antibody Affinity Maturation
Cai, H., Zhang, Z., Wang, M., Zhong, B., Wu, Y., Ying, T., Tang, J.
10.1101/2023.08.10.552845 — Posted: 2023-08-11
Additive Manufacturing Leveraged Microfluidic Setup for Sample to Answer Colorimetric Detection of Pathogens
Yedire, S. G., Hosseini, I. I., Shieh, H., Jahromi, A. K., Fatah, T. A., Jalali, M., Mahshid, S.
10.1101/2023.08.10.552726 — Posted: 2023-08-11
Self-tests for COVID-19: what is the evidence? A living systematic review and meta-analysis (2020-2023)
Anand, A., Vialard, F., Esmail, A., Ahmad Khan, F., O'Byrne, P., Routy, J.-P., Dheda, K., Pant Pai, N.
10.1101/2023.08.09.23293885 — Posted: 2023-08-10
Waning of post-vaccination neutralizing antibody responses against SARS-CoV-2, a systematic literature review and meta-analysis
Jacobsen, H., Sitaras, I., Katzmarzyk, M., Cobos Jimenez, V., Naughton, R., Higdon, M. M., Deloria Knoll, M.
10.1101/2023.08.08.23293864 — Posted: 2023-08-10
Iterative In Silico Screening for Optimizing Stable Conformation of Anti-SARS-CoV-2 Nanobodies
Shang, W., Hu, X., Lin, X., Li, S., Xiong, S., Huang, B., Wang, X.
10.1101/2023.08.09.552633 — Posted: 2023-08-10
Enhanced Deep Convolutional Neural Network for SARS-CoV-2 Variants Classification
Awe, O. I., obura, h. o., Mwanga, M. J., Evans, M.
10.1101/2023.08.09.552643 — Posted: 2023-08-10
Development and Analytical Evaluation of a Point-of-Care Electrochemical Biosensor for Rapid and Accurate SARS-CoV-2 Detection
Meshesha, M., Sardar, A., Supekar, R., Bhattacharjee, L., Chatterjee, S., Halder, N., Mohanta, K., Pal, B.
10.1101/2023.08.08.552470 — Posted: 2023-08-10
Open-source milligram-scale, four channel, automated protein purification system
Puccinelli, R. R., Sama, S. S., Worthington, C. M., Puschnik, A. S., Pak, J. E., Gomez-Sjoberg, R.
10.1101/2023.08.09.552685 — Posted: 2023-08-10
High-throughput detection of neutralizing antibodies to SARS-CoV-2 variants using flow cytometry
Zhang, X., Wang, Y., Li, M., Li, H., Zhang, X., Xu, X., Hu, D., Liang, T., Zhu, Y., Li, Y., Wang, B., Yu, X.
10.1101/2023.08.07.23293304 — Posted: 2023-08-09
Diabetes following SARS-CoV-2 infection: Incidence, persistence, and implications of COVID-19 vaccination. A cohort study of fifteen million people.
Taylor, K., Eastwood, S., Walker, V., Cezard, G., Knight, R., Al Arab, M., Wei, Y., Horne, E. M. F., Teece, L., Forbes, H., Walker, A., Fisher, L., Massey, J., Hopcroft, L. E. M., Palmer, T., Cuitun Coronado, J., Ip, S., Davy, S., Dillingham, I., Morton, C., Greaves, F., MacLeod, J., Goldacre, B., Wood, A., Chaturvedi, N., Sterne, J. A. C., Denholm, R., CONVALESCENCE Long-COVID study, , Longitudinal Health and Wellbeing and Data and Connectivity UK COVID-19 National Core Studies, , OpenSAFELY collaborative
10.1101/2023.08.07.23293778 — Posted: 2023-08-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).